Mylan Gmbh

Elan Pharma International Limited

Other

Alkermes Pharma Ireland Limited

Kevin D Ostrander

John W Denny

H William Bosch

Eugene Rex Cooper

Douglas C Hovey

Stephen B Ruddy

Niels Peter Ryde

Rajeev A Jain

Laura Kline

Greta G Cary

Elaine Merisko-Liversidge

Donna M Marcera

Douglas A White

Various exemplary embodiments relate to a method of using an emergency medicament device. The method includes reading an ID tag from the medicament device using a mobile device; automatically requesting instructions for using the medicament device based on the ID tag; and displaying a video to a user of the mobile device, the video providing instructions for using the medicament device in accordance with approved labeling of the medicament device. Various exemplary embodiments relate to an electronic medicament device including: a reservoir configured to store an amount of medication for treating anaphylaxis; an administration component for administering the medication to a patient; a processor communicatively connected to a memory storing medicament device information; and an identification tag configured to be read by another device, the identification tag providing the medicament device information including identification of instructions for using the medicament device.

Medicament information system and method

Various exemplary embodiments relate to an electronic device for dispensing a medicament. The electronic device may include a medicament storage case or an electronic medicament device. The medicament storage case includes: a door moveable between an open position and a closed position; a lock moveable between a locked position where the lock maintains the door in the closed position and an unlocked position where the lock allows the door to move to the open position; a medicament dispensing device containing medication; an input device located on an external surface of the storage case activatable by a user; a communication unit configured to initiate a two-way communication between the user and a remote access control center upon activation of the input device and configured to receive an access signal from the remote access control center; and an actuator responsive to the access signal to move the lock to the open position upon receipt of the communication from the remote access control center. The electronic medicament device includes a reservoir configured to store an amount of medication, an administration component for administering the medication to a patient, and a processor communicatively connected to a memory.

Medicament storage, dispensing, and administration system and method

Various exemplary embodiments relate to a method, device, and storage medium including one or more of the following: receiving location information and expiration information; determining a current location of the mobile device; determining that the medicament device is within a predetermined distance from the mobile device; determining that the medicament device is currently associated with an expiration event; outputting an expiration alarm indicating the expiration event in response to determining that the medicament device is within a predetermined distance from the mobile device and that the medicament device is currently associated with an expiration event; receiving, from the user, a request to display a map of a geographic area; displaying, by the mobile device and via a non-operating system application, the map of the geographic area; and displaying an alert icon on the map, wherein the location of the icon on the map is based on the received location information.

Various exemplary embodiments relate to a medicament storage case including: a case body securable to a wall; a door connected to the body; a sleeve to contain an epinephrine injector; a medicament lock including a hook, wherein the hook is positioned to engage the sleeve when in a first position and is positioned to disengage the sleeve when in a second position; an actuator including a solenoid, wherein the solenoid, upon activation, moves the hook from the first position to the second position; a microphone configured to receive first audio as input; a speaker configured to output second audio; a communication unit configured to provide Internet connectivity; a button; and a processor configured to: in response to pressing the button: establish communication between the local user and a remote site, receive an unlock message, and in response to receiving the unlock message, activate the solenoid to release of the sleeve.

System and method for medicament storage, dispensing, and administration

Various exemplary embodiments relate to a method, device, and non-transitory machine-readable storage medium encoded with instructions for execution by a user device, the medium comprising: instructions for displaying an indication of an incoming request to establish a communication session with a patient operating a medication dispenser; instructions for establishing a two-way communication session with the patient via the medication dispenser based on a physician user of the user device approving the incoming request; instructions for displaying a dispense user interface (UI) element during the two-way communication session; instructions for receiving a selection of the dispense UI element from the physician user; and instructions for transmitting, based on the selection, a command for the medication dispenser to dispense a medication to the patient.

There invention discloses aqueous dispersions of nanoparticulate aerosol formulations, dry powder nanoparticulate aerosol formulation, propellant-based aerosol formulations, methods of using the formulations in aerosol delivery devices, and methods of making such formulations. The nanoparticles of the aqueous dispersions or dry powder formulations comprise insoluble drug particles having a surface modifier on the surface thereof.

Propellant-based nanoparticulate dry powder aerosols and method of making

Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.

Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors

Dry powder aerosols of nanoparticulate drugs

Liquid droplet aerosols of nanoparticulate drugs

Nanoparticulate amorphous cyclosporine formulations, and nanoparticulate cyclosporine formulations comprising a mixture of amorphous and crystalline cyclosporine, having effective average particle sizes of less than about 2000 nm are described. The compositions exhibit increased bioavailability and increased consistency of bioavailability as compared to prior macro-sized cyclosporine and formulations. Methods of making and using the compositions are also described.

Growing community of inventors

Reading, PA, United States of America

Kevin D Ostrander